Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role

Recently, the FDA approved the first 2 RSV vaccines for adults aged 60 years or older. As healthcare professionals serving in key roles throughout care settings, we welcome pharmacists to join us in this multimodal educational program to learn strategies to incorporate RSV vaccination in your practice, methods of identifying patients who would benefit from RSV prevention, and tools to provide evidence-based and up-to-date education.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner